Lilly Preparing For Increasing Mounjaro Demand On Top Of Solid Launch

 
• By Joseph Haas
Eli Lilly logo sign atop Lilly Biotechnology Center campus of an American pharmaceutical company Eli Lilly and Company
Tirzepatide may soon compete with semaglutide in two major indications • Source: Shutterstock

More from Earnings

More from Business